CT Market Size, Share, Growth, and Industry Analysis, By Type (2S Spiral Scan CT,16S Spiral Scan CT,64S Spiral Scan CT,128S Spiral Scan CT,256S Spiral Scan CT,Others), By Application (Head,Lungs,Pulmonary angiogram,Cardiac,Abdominal and pelvic,Extremities), Regional Insights and Forecast to 2035

CT Market Overview

The global CT Market size is projected to grow from USD 6067.23 million in 2026 to USD 6235.9 million in 2027, reaching USD 7762.93 million by 2035, expanding at a CAGR of 2.78% during the forecast period.

The CT Market includes over 6.45 billion diagnostic procedures globally in 2024, with more than 70 million CT scans performed annually in the United States alone, covering bone, soft tissue, and vascular imaging.

The USA CT Market supports over 70 million CT scans annually, with head, lung, and cardiac imaging each accounting for approximately 15–20 percent of applications.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: High-slice CT scanners contribute approximately 35 percent to market demand due to superior imaging capabilities.
• Major Market Restraint: Mobile CT adoption remains under 20 percent, limiting flexibility for rural and emergency diagnostics.
• Emerging Trends: Oncology applications account for about 30 percent of CT scan use, leading growth in CT Market Trends.
• Regional Leadership: North America holds approximately 34 percent share, dominating the CT Market Outlook regionally.
• Competitive Landscape: Top five CT manufacturers control nearly 70 percent of device share globally.
• Market Segmentation: Multi-slice spiral CT represents about 70 percent of CT device installations worldwide.
• Recent Development: Portable/mobile CT scanners comprise nearly 60 percent of modality share in 2025.

CT Market Latest Trends

The CT Market Report emphasizes rising demand for multi-slice spiral CT, which now represents 70 percent of global installations, largely replacing legacy systems such as single-slice and conventional CT devices. Stationary CT scanners maintain a 79.8 percent share of installed base, while mobile and portable CT units continue growing and hold nearly 60 percent share in 2025, improving access to remote and emergency care.

CT Market Dynamics

The CT Market Dynamics highlight the shifting balance between technological progress, adoption barriers, clinical opportunities, and operational challenges. Key drivers include rising deployment of multi-slice spiral CT systems (now about 70 percent of installations) and their ability to deliver faster, more accurate imaging across oncology, cardiology, and neurology.

DRIVER

"Technological Advancement in Multi-Slice CT Systems"

Technological enhancements in multi-slice spiral CT systems have become the primary driver of CT Market Growth. Multi-slice systems, especially those with 64- and 128-slice capability, now account for an estimated 70 percent of CT installations, significantly surpassing single-slice and non-spiral CT variants.

RESTRAINT

"Limited Penetration of Mobile/Portable CT Systems"

Despite advantages in flexibility, mobile CT units remain under 20 percent of the global modality segment, limiting CT Market Restraint. Mobile CT scanners, suitable for emergency departments and remote care, have not replaced stationary installations, which still account for 79.8 percent of devices.

OPPORTUNITY

"Expansion in Oncology Imaging Applications"

Oncology is the largest CT application, accounting for approximately 30 percent of scan volumes, presenting a major CT Market Opportunity. CT remains central to cancer diagnostics, follow-up, and treatment monitoring.

CHALLENGE

"Skilled Workforce Shortage in Radiologic Technicians"

A significant challenge within the CT Market is the shortage of trained radiologic technologists to operate advanced CT systems. Annual training programs produce fewer than 5 technicians per million population in emerging economies.

CT Market Segmentation

The CT Market is segmented by type 2S, 16S, 64S, 128S, 256S Spiral Scan CT, and Others and by application, including Head, Lungs (Pulmonary angiogram), Cardiac, Abdominal & Pelvic, and Extremities. Single-slice CT accounts for approximately 20 percent of device share, while Multi-slice covers 70 percent; the remaining 10 percent comprises non-spiral and alternative systems.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

2S Spiral Scan CT: 2S spiral CT systems, representing approximately 2–5 percent of installed CT devices, are legacy systems predominantly used in rural and low-income regions. These units deliver basic anatomical imaging at lower capital cost, with limited slice performance and slower throughput. In 2022, over 5,000 of such systems remained operational in resource-constrained healthcare facilities.

The 2S Spiral Scan CT segment is anticipated to hold USD 623.45 million in 2025, expanding to USD 792.67 million by 2034, accounting for an estimated 10.4% share at a 2.72% CAGR

Top 5 Major Dominant Countries in the 2S Spiral Scan CT Segment

• United States: The U.S. is forecasted to reach USD 223.78 million in 2025, rising to USD 284.45 million by 2034, representing a 35.8% share with a 2.69% CAGR, driven by broad diagnostic and emergency care applications.
• Germany: Germany is estimated at USD 102.34 million in 2025, reaching USD 130.56 million by 2034, holding a 16.4% share at 2.74% CAGR, reflecting demand from advanced medical centers and radiology departments.
• China: China’s market is expected at USD 95.67 million in 2025, expanding to USD 123.98 million by 2034, maintaining a 15.3% share with a 2.78% CAGR, supported by expansion in diagnostic healthcare infrastructure.
• United Kingdom: The UK records USD 77.45 million in 2025, forecasted to reach USD 100.21 million by 2034, capturing a 12.4% share with a 2.76% CAGR, aligned with the growing preference for compact imaging technologies.
• India: India is valued at USD 56.21 million in 2025, projected to rise to USD 72.13 million by 2034, representing a 9% share at a 2.81% CAGR, supported by increasing hospital adoption in tier-2 and tier-3 cities.

16S Spiral Scan CT: 16S spiral CT devices account for roughly 15 percent of CT installations. These mid-range systems are commonly deployed in regional hospitals and small imaging centers for standard indications such as head, lung, and abdominal scans.

The 16S Spiral Scan CT market is valued at USD 987.56 million in 2025, projected to expand to USD 1264.11 million by 2034, with a 16.7% share and a 2.75% CAGR, reflecting widespread use in diagnostic imaging centers.

Top 5 Major Dominant Countries in the 16S Spiral Scan CT Segment

• United States: Market estimated at USD 325.12 million in 2025, growing to USD 418.78 million by 2034, holding a 32.9% share at 2.73% CAGR, largely driven by multi-departmental imaging demand across healthcare networks.
• China: China reaches USD 245.67 million in 2025, projected to rise to USD 315.12 million by 2034, holding 24.8% share with 2.77% CAGR.
• Germany: Germany is at USD 146.89 million in 2025, reaching USD 187.45 million by 2034, capturing 14.9% share with a 2.74% CAGR, supported by integration in specialized imaging facilities.
• Japan: Japan is expected at USD 132.21 million in 2025, expanding to USD 167.67 million by 2034, representing 13.4% share at 2.75% CAGR, driven by demand in technologically advanced hospitals and clinics.
• India: India’s market is projected at USD 90.34 million in 2025, increasing to USD 116.09 million by 2034, accounting for 9.1% share with 2.81% CAGR, supported by diagnostic lab growth across metropolitan and rural areas.

64S Spiral Scan CT: 64S spiral CT comprises around 35–38 percent of the installed CT base and is favored in tertiary hospitals. These systems balance speed and image quality, performing rapid cardiac and full-body studies. 

The 64S Spiral Scan CT segment is projected to achieve USD 1,543.22 million in 2025, increasing steadily to USD 1,979.65 million by 2034, representing 26.1% market share with a 2.79% CAGR

Top 5 Major Dominant Countries in the 64S Spiral Scan CT Segment

• United States: The U.S. is forecasted at USD 512.34 million in 2025, rising to USD 656.23 million by 2034, capturing a 33.1% share with a 2.77% CAGR, driven by demand in oncology and cardiovascular diagnostics.
• Germany: Germany holds USD 284.56 million in 2025, reaching USD 364.12 million by 2034, maintaining 18.4% share with 2.80% CAGR, reflecting investments in tertiary care centers and radiological imaging upgrades.
• China: China is expected at USD 265.12 million in 2025, projected to expand to USD 343.78 million by 2034, securing 17.1% share with 2.83% CAGR, driven by rising diagnostic utilization in public hospitals.
• Japan: Japan is valued at USD 234.11 million in 2025, growing to USD 299.67 million by 2034, representing 15.2% share with 2.79% CAGR, fueled by the adoption of high-speed CT scanning in advanced care settings.
• United Kingdom: The UK market stands at USD 187.09 million in 2025, expected to reach USD 248.12 million by 2034, holding 12.1% share with 2.78% CAGR, supported by a strong base of diagnostic imaging centers.

128S Spiral Scan CT: 128S CT systems account for around 15 percent of installations and are used in advanced cardiac and oncology imaging, with faster gantry rotation and high-resolution outputs. Centers using 128S scanners report 20 percent higher diagnostic throughput due to scan flexibility.

The 128S Spiral Scan CT market is projected at USD 1,102.89 million in 2025, expected to grow and reach USD 1,412.23 million by 2034.

Top 5 Major Dominant Countries in the 128S Spiral Scan CT Segment

• United States: Estimated at USD 356.21 million in 2025, projected to reach USD 462.11 million by 2034, holding 32.2% share with 2.75% CAGR, fueled by premium hospital installations and cardiovascular diagnostics.
• China: China reaches USD 278.67 million in 2025, projected to grow to USD 362.34 million by 2034, accounting for 25.2% share with 2.77% CAGR, reflecting strong adoption in metropolitan diagnostic facilities.
• Germany: Germany is forecasted at USD 178.43 million in 2025, increasing to USD 232.56 million by 2034, capturing 16.2% share with 2.74% CAGR, supported by academic hospitals and clinical research deployments.
• Japan: Japan’s market size stands at USD 154.67 million in 2025, expanding to USD 201.89 million by 2034, representing 14% share with 2.75% CAGR, linked to the demand for advanced radiology services.
• India: India is valued at USD 135.22 million in 2025, projected to reach USD 173.33 million by 2034, holding 12.2% share with 2.80% CAGR, supported by diagnostic chain expansions and increasing medical tourism.

256S Spiral Scan CT: 256S CT units, representing 5–10 percent of systems, are highly specialized for high-volume cardiac, neuro, and trauma imaging, enabling ultra-fast volumetric data. These are commonly found in elite hospitals and diagnostic chains.

The 256S Spiral Scan CT segment is projected to attain USD 1,067.45 million in 2025, rising to USD 1,372.22 million by 2034, with a 17.5% market share at a 2.78% CAGR, favored for detailed organ imaging and comprehensive multi-organ scans.

Top 5 Major Dominant Countries in the 256S Spiral Scan CT Segment

• United States: The U.S. is forecasted at USD 365.67 million in 2025, expanding to USD 467.45 million by 2034, capturing 34.2% share with 2.77% CAGR, reflecting growing cardiac and neurological diagnostic demand.
• Germany: Germany holds USD 196.11 million in 2025, increasing to USD 252.98 million by 2034, representing 18.4% share with 2.79% CAGR, aligned with innovation in advanced imaging protocols.
• China: China records USD 182.22 million in 2025, projected to expand to USD 236.78 million by 2034, accounting for 17% share with 2.80% CAGR, supported by rapid modernization of hospital imaging capacities.
• Japan: Japan is at USD 156.78 million in 2025, rising to USD 204.12 million by 2034, holding 14.6% share with 2.78% CAGR, boosted by precision-driven imaging and advanced clinical adoption.
• United Kingdom: The UK is projected at USD 131.67 million in 2025, growing to USD 170.89 million by 2034, representing 12.3% share with 2.77% CAGR, supported by diagnostic excellence in specialized hospitals.

Others: The ‘Others’ category including cone-beam CT, electron beam CT, and portable models constitutes around 5 percent of global installations, serving niche and mobile applications in emergency, intraoperative, or remote diagnostics.

The "Others" category, comprising hybrid and emerging CT models, is estimated at USD 578.01 million in 2025, projected to grow to USD 732.07 million by 2034, securing 9.7% market share with a 2.77% CAGR, reflecting adoption of niche diagnostic systems.

Top 5 Major Dominant Countries in the Others Segment

• United States: The U.S. is forecasted at USD 212.45 million in 2025, rising to USD 270.12 million by 2034, maintaining a 36.6% share with 2.76% CAGR, driven by academic adoption of innovative CT prototypes.
• Germany: Germany’s market is valued at USD 97.11 million in 2025, growing to USD 123.34 million by 2034, representing 16.8% share with 2.78% CAGR, driven by investments in hybrid imaging platforms.
• China: China stands at USD 88.56 million in 2025, expanding to USD 114.98 million by 2034, capturing 15.6% share with 2.79% CAGR, supported by pilot adoption in tertiary hospitals.
• Japan: Japan is forecasted at USD 76.23 million in 2025, rising to USD 98.12 million by 2034, holding 13.2% share with 2.77% CAGR, aligned with early adoption of dual-energy systems.
• United Kingdom: The UK market is projected at USD 62.34 million in 2025, reaching USD 79.51 million by 2034, maintaining 10.7% share with 2.78% CAGR, supported by gradual integration into advanced imaging pathways.

BY APPLICATION

Head: Head applications represent approximately 30 percent of CT scan volumes, with more than 20 million head CTs performed annually globally. These scans are vital for stroke, trauma, tumor, and neurological disorder diagnosis, particularly in emergency departments.

The Head CT application is valued at USD 1,432.67 million in 2025, projected to reach USD 1,827.56 million by 2034, holding a 24.2% market share with 2.78% CAGR, primarily driven by neurological diagnostics, trauma assessments, and early detection of brain-related disorders.

Top 5 Major Dominant Countries in the Head CT Application

• United States: Forecasted at USD 478.34 million in 2025, expanding to USD 610.78 million by 2034, securing 33.4% share with 2.77% CAGR, supported by extensive neurological imaging and stroke detection procedures.
• China: Estimated at USD 302.12 million in 2025, rising to USD 386.23 million by 2034, holding 21% share with 2.79% CAGR, driven by trauma care and emergency imaging demand.
• Germany: Germany stands at USD 211.78 million in 2025, projected to grow to USD 272.12 million by 2034, capturing 14.8% share with 2.78% CAGR, supported by high prevalence of neurodegenerative conditions.
• Japan: Japan is valued at USD 190.34 million in 2025, rising to USD 243.56 million by 2034, maintaining 13.2% share with 2.77% CAGR, reflecting advanced healthcare infrastructure for neurology.
• United Kingdom: UK market is expected at USD 150.09 million in 2025, reaching USD 192.87 million by 2034, with 10.5% share and 2.78% CAGR, driven by trauma imaging in emergency departments.

Lungs (Pulmonary Angiogram): Lung imaging, including pulmonary angiogram applications, accounts for roughly 25 percent of total CT procedures, with around 15 million lung CT scans conducted annually driven by rising incidence of pulmonary embolism and pneumonia.

The Lung CT application is projected at USD 1,289.45 million in 2025, anticipated to reach USD 1,654.33 million by 2034, holding a 21.9% share with a 2.79% CAGR, supported by increasing cases of chronic respiratory diseases and lung cancer screenings.

Top 5 Major Dominant Countries in the Lung CT Application

• United States: Valued at USD 432.23 million in 2025, expanding to USD 556.12 million by 2034, representing 33.5% share with 2.78% CAGR, reflecting strong lung cancer screening programs.
• China: China’s market size at USD 280.12 million in 2025, projected to reach USD 363.89 million by 2034, capturing 21.7% share with 2.80% CAGR, supported by respiratory disorder prevalence.
• Germany: Estimated at USD 195.09 million in 2025, increasing to USD 251.11 million by 2034, securing 15.1% share with 2.78% CAGR, driven by COPD and asthma diagnostic demand.
• Japan: Japan records USD 185.22 million in 2025, growing to USD 239.12 million by 2034, representing 13.7% share with 2.77% CAGR, reflecting advanced imaging adoption for pulmonary health.
• India: India is projected at USD 146.79 million in 2025, expected to expand to USD 196.09 million by 2034, holding 11.3% share with 2.81% CAGR, driven by rising tobacco-related lung diseases.

Cardiac: Cardiac CT comprises nearly 20 percent of CT usage, with approximately 10 million cardiac scans performed yearly. These are crucial for coronary artery evaluation and pre-surgical planning, aided by high-slice systems enabling precise 3D imaging.

The Cardiac CT application is projected at USD 1,045.78 million in 2025, growing to USD 1,334.56 million by 2034, with a 17% share and a 2.78% CAGR, reflecting increased use in coronary artery imaging and heart disease diagnostics.

Top 5 Major Dominant Countries in Cardiac CT Application

• United States: U.S. market is USD 375.12 million in 2025, reaching USD 480.34 million by 2034, maintaining 35.8% share with 2.77% CAGR, driven by cardiac health initiatives.
• Germany: Germany stands at USD 182.09 million in 2025, projected to rise to USD 231.45 million by 2034, with 17.2% share and 2.79% CAGR, linked to advanced cardiac diagnostic centers.
• China: Estimated at USD 163.78 million in 2025, increasing to USD 209.22 million by 2034, holding 15.7% share with 2.80% CAGR, supported by cardiovascular health demand.
• Japan: Japan records USD 155.23 million in 2025, projected to expand to USD 198.78 million by 2034, representing 14.9% share with 2.78% CAGR, supported by aging population-driven demand.
• India: India’s market is USD 128.56 million in 2025, rising to USD 164.77 million by 2034, securing 12.2% share with 2.81% CAGR, driven by rising cases of coronary artery disease.

Abdominal and Pelvic: Abdominal and pelvic CT scans account for about 15 percent of applications, with 8 million scans performed annually for gastro-intestinal and urological diagnostics.

The Abdominal and Pelvic CT application is estimated at USD 764.34 million in 2025, expected to grow to USD 973.21 million by 2034, with a 12.9% share and 2.77% CAGR, widely used in gastrointestinal and reproductive system diagnostics.

Top 5 Major Dominant Countries in Abdominal & Pelvic Application

• United States: U.S. stands at USD 265.11 million in 2025, projected to reach USD 339.78 million by 2034, capturing 34.7% share with 2.78% CAGR, driven by oncology and abdominal diagnostics.
• Germany: Germany is valued at USD 147.09 million in 2025, growing to USD 187.11 million by 2034, representing 19.1% share with 2.79% CAGR, supported by imaging in gastrointestinal research.
• China: China is projected at USD 139.12 million in 2025, expanding to USD 176.34 million by 2034, holding 18.1% share with 2.80% CAGR, fueled by increased abdominal cancer cases.
• Japan: Japan is estimated at USD 125.78 million in 2025, increasing to USD 159.67 million by 2034, representing 16.4% share with 2.78% CAGR, aligned with gynecology and pelvic imaging use.
• United Kingdom: The UK holds USD 87.24 million in 2025, projected to reach USD 110.31 million by 2034, accounting for 11.4% share with 2.77% CAGR, driven by specialized oncology imaging.

Extremities: Imaging of extremities for fractures, musculoskeletal assessment, and postoperative follow-up accounts for approximately 10 percent of CT applications.

The Extremities CT application is valued at USD 358.99 million in 2025, projected to reach USD 468.07 million by 2034, representing 6.1% share with 2.78% CAGR, utilized in musculoskeletal, bone fracture, and orthopedic imaging procedures.

Top 5 Major Dominant Countries in Extremities CT Application

• United States: U.S. market is forecasted at USD 126.67 million in 2025, rising to USD 165.34 million by 2034, holding 35.5% share with 2.77% CAGR, strongly driven by orthopedic imaging.
• Germany: Germany is projected at USD 72.45 million in 2025, growing to USD 93.12 million by 2034, capturing 20.1% share with 2.79% CAGR, reflecting sports medicine imaging.
• China: China’s market is valued at USD 69.34 million in 2025, projected to reach USD 89.12 million by 2034, securing 19.3% share with 2.80% CAGR, supported by musculoskeletal disease prevalence.
• Japan: Japan records USD 58.21 million in 2025, rising to USD 75.45 million by 2034, holding 16.1% share with 2.78% CAGR, focused on bone and joint imaging.
• India: India is valued at USD 52.32 million in 2025, expanding to USD 67.04 million by 2034, representing 14.8% share with 2.81% CAGR, driven by increasing trauma cases.

Regional Outlook for the CT Market

Summary: Global CT Market is dominated by North America (34 percent share), followed by Asia-Pacific (26 percent), Europe (24 percent), and Middle East & Africa (6 percent). Regional variations reflect differences in technology adoption, healthcare infrastructure, and application demand.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds approximately 34 percent of the global CT Market, the largest regional share in 2024. The U.S. alone performs over 70 million CT scans annually, with head imaging accounting for 30 percent, lung imaging near 25 percent, and cardiac scans about 20 percent.

The North America CT market is estimated at USD 1,890.56 million in 2025, projected to reach USD 2,395.12 million by 2034, representing 32% global share with 2.78% CAGR, driven by advanced healthcare infrastructure and high diagnostic imaging adoption.

"North America – Major Dominant Countries in the CT Market"

• United States: The U.S. market stands at USD 1,345.89 million in 2025, projected to reach USD 1,703.34 million by 2034, capturing 71.2% of regional share with 2.77% CAGR, reflecting leadership in diagnostic and oncology imaging adoption.
• Canada: Canada holds USD 292.45 million in 2025, increasing to USD 368.89 million by 2034, maintaining 15.4% share with 2.79% CAGR, supported by investments in advanced imaging systems across tertiary hospitals.
• Mexico: Mexico is forecasted at USD 142.22 million in 2025, expanding to USD 182.89 million by 2034, securing 7.5% share with 2.80% CAGR, driven by improving diagnostic care and rising cancer detection programs.
• Cuba: Cuba’s CT market is valued at USD 65.34 million in 2025, projected to reach USD 84.21 million by 2034, with 3.4% share and 2.77% CAGR, reflecting modernization of imaging centers.
• Dominican Republic: The Dominican Republic records USD 44.66 million in 2025, growing to USD 56.79 million by 2034, capturing 2.5% share with 2.78% CAGR, linked to growth in diagnostic imaging demand.

EUROPE

Europe holds around 24 percent of the CT Market share, second only to North America. The region has a high density of high-slice CT systems, with 64-slice units representing 35–40 percent of installations in countries like Germany and the U.K. Head and lung imaging are dominant applications, each capturing approximately 25–30 percent of CT scan volumes.

The Europe CT market is valued at USD 1,534.77 million in 2025, expected to expand to USD 1,943.89 million by 2034, holding 26% of global share with 2.78% CAGR, strongly supported by high demand in neurological and cardiovascular imaging.

Europe – Major Dominant Countries in the CT Market

• Germany: Germany is estimated at USD 478.12 million in 2025, growing to USD 604.45 million by 2034, representing 31.1% regional share with 2.79% CAGR, supported by strong healthcare investments in radiology.
• United Kingdom: The UK market is valued at USD 342.78 million in 2025, projected to reach USD 432.67 million by 2034, holding 22.3% share with 2.77% CAGR, reflecting expanded usage in trauma and oncology care.
• France: France stands at USD 276.45 million in 2025, growing to USD 351.12 million by 2034, capturing 18% share with 2.78% CAGR, driven by cardiology and cancer diagnostic applications.
• Italy: Italy records USD 246.23 million in 2025, projected to expand to USD 311.67 million by 2034, securing 16% share with 2.78% CAGR, reflecting government-backed imaging modernization initiatives.
• Spain: Spain’s CT market is USD 191.19 million in 2025, expanding to USD 242.34 million by 2034, maintaining 12.5% share with 2.77% CAGR, supported by cardiovascular and neurology diagnostic imaging programs.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 26 percent of global CT installations, emerging as a fastest-growing region. China leads with about 10,000 CT scanners installed across hospitals, with multi-slice systems comprising over 60 percent. India follows, with around 3,500 CT units, where single- and 16-slice scanners still hold 25 percent share due to affordability, while multi-slice devices are gaining ground.

The Asia CT market is forecasted at USD 1,534.22 million in 2025, projected to expand to USD 1,987.11 million by 2034, representing 26.3% global share with 2.80% CAGR, supported by rapid expansion of healthcare infrastructure and rising patient populations.

Asia – Major Dominant Countries in the CT Market

• China: China leads with USD 584.45 million in 2025, projected to reach USD 755.22 million by 2034, capturing 38.1% regional share with 2.81% CAGR, reflecting high demand for oncology and pulmonary imaging.
• Japan: Japan stands at USD 432.78 million in 2025, expanding to USD 553.11 million by 2034, holding 28.2% share with 2.77% CAGR, supported by aging population needs and advanced radiology use.
• India: India is projected at USD 267.34 million in 2025, expected to grow to USD 354.45 million by 2034, capturing 17.4% share with 2.81% CAGR, reflecting rapid adoption of CT imaging in oncology and cardiology.
• South Korea: South Korea is valued at USD 145.89 million in 2025, expanding to USD 191.56 million by 2034, representing 9.5% share with 2.78% CAGR, supported by technological adoption in radiology departments.
• Australia: Australia records USD 104.33 million in 2025, projected to reach USD 132.77 million by 2034, holding 6.8% share with 2.77% CAGR, reflecting early adoption of high-slice CT technology.

MIDDLE EAST & AFRICA

Middle East & Africa represent approximately 6 percent of global CT installations. Saudi Arabia and UAE lead regional CT deployment with over 500 CT units each, focusing on high-slice systems (64S and above), which account for around 50 percent of installations.

The Middle East & Africa CT market is estimated at USD 943.57 million in 2025, projected to grow to USD 1,226.84 million by 2034, holding 15.7% global share with 2.79% CAGR, driven by increasing demand for advanced medical imaging services.

Middle East & Africa – Major Dominant Countries in the CT Market

• Saudi Arabia: Saudi Arabia is forecasted at USD 278.34 million in 2025, reaching USD 362.56 million by 2034, securing 29.5% share with 2.80% CAGR, supported by strong healthcare investments in imaging.
• United Arab Emirates: UAE is valued at USD 198.11 million in 2025, projected to grow to USD 257.45 million by 2034, capturing 21% share with 2.79% CAGR, reflecting expanding advanced hospital infrastructure.
• South Africa: South Africa stands at USD 163.22 million in 2025, rising to USD 210.78 million by 2034, representing 17.3% share with 2.77% CAGR, driven by trauma and oncology imaging demand.
• Egypt: Egypt’s CT market is USD 152.34 million in 2025, expected to reach USD 198.12 million by 2034, maintaining 16.1% share with 2.78% CAGR, supported by expansion of public diagnostic imaging centers.
• Nigeria: Nigeria records USD 102.67 million in 2025, projected to reach USD 133.93 million by 2034, holding 10.8% share with 2.80% CAGR, reflecting growing imaging demand in urban hospitals.

List of Top CT Companies

• Shenzhen Anke High-tech
• Hitachi
• Shimadzu
• United Imaging
• Philips
• Carestream Healthcare
• NeuroLogica
• Toshiba
• Siemens
• GE Healthcare
• Neusoft Medical

Siemens: Siemens dominates the CT market with more than 18% global market share.

GE Healthcare: GE Healthcare holds approximately 17% share in the CT market.

Investment Analysis and Opportunities

Investment activity in the CT Market focuses on high-slice scanner deployment, oncology imaging platforms, and mobile CT infrastructure. Hospitals account for over 60 percent of CT usage, prompting investment in 64- and 128-slice systems that deliver higher throughput and diagnostic precision.

New Product Development

Recent innovation in the CT Market centers on high-slice and mobile technologies, as well as AI-enabled workflow enhancements. In 2024, over 35 percent of new CT systems deployed globally were 128-slice or higher configurations, delivering ultra-fast, high-resolution imaging. Portable CT units made up nearly 60 percent of new modality additions, particularly in emergency care and rural hospital settings, providing flexibility and reducing infrastructure constraints.

Five Recent Developments

• Multi-slice CT installations surpassed 30,000 units globally by 2023, enabling 50 million scans annually.
• Portable/mobile CT systems captured 60 percent of new modality adoption in 2025.
• Oncology CT usage reached 30 percent of total scan volume in 2024.
• North America held 34 percent of CT installations in 2023, the highest globally.
• Asia-Pacific region was fastest-growing, holding 26 percent of CT Market share in 2024.

Report Coverage of CT Market

This CT Market Report delivers extensive coverage of device types from legacy 2S spiral CT to advanced 256S spiral systems covering multi-slice dominance (70 percent share), single-slice (20 percent), and other variants (10 percent). It details application segmentation: Head (30 percent), Lungs (25 percent), Cardiac (20 percent), Abdominal and Pelvic (15 percent), and Extremities (10 percent).

CT Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 6067.23 Million in 2026
Market Size Value By	USD 7762.93 Million by 2035
Growth Rate	CAGR of 2.78% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : 2S Spiral Scan CT 16S Spiral Scan CT 64S Spiral Scan CT 128S Spiral Scan CT 256S Spiral Scan CT Others By Application : Head Lungs Pulmonary angiogram Cardiac Abdominal and pelvic Extremities
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample